Recruiting Geographic Atrophy Studies in Lexington
About Geographic Atrophy Clinical Trials in Lexington
Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.
There are currently 5 geographic atrophy clinical trials recruiting participants in Lexington, KY. These studies are seeking a combined 2,667 participants. Research is being sponsored by Shire, University of Calgary, SK Life Science, Inc. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Geographic Atrophy Clinical Trials in Lexington — FAQ
Are there geographic atrophy clinical trials in Lexington?
Yes, there are 5 geographic atrophy clinical trials currently recruiting in Lexington, KY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Lexington?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lexington research site will contact you about next steps.
Are clinical trials in Lexington free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lexington studies also compensate for your time and travel.
What geographic atrophy treatments are being tested?
The 5 active trials in Lexington are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.
Data updated October 22, 2026 from ClinicalTrials.gov